Metabolomics, metabolic flux analysis and cancer pharmacology

Metabolic reprogramming is a hallmark of cancer and increasing evidence suggests that reprogrammed cell metabolism supports tumor initiation, progression, metastasis and drug resistance. Understanding metabolic dysregulation may provide therapeutic targets and facilitate drug research and developmen...

Full description

Saved in:
Bibliographic Details
Published inPharmacology & therapeutics (Oxford) Vol. 224; p. 107827
Main Authors Liang, Lingfan, Sun, Fei, Wang, Hongbo, Hu, Zeping
Format Journal Article
LanguageEnglish
Published England Elsevier Inc 01.08.2021
Subjects
Online AccessGet full text

Cover

Loading…